Plandai Biotech
Plandaí Biotechnology, Inc. does not have significant operations. Previously, it was involved in a biotechnology-related business. Plandaí Biotechnology, Inc. is based in Taipei, Taiwan.
Market Cap & Net Worth: Plandai Biotech (PLPL)
Plandai Biotech (PINK:PLPL) has a market capitalization of $4.49 Million ($4.49 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #44037 globally and #14021 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Plandai Biotech's stock price $0.00 by its total outstanding shares 44889534371 (44.89 Billion).
Plandai Biotech Market Cap History: 2015 to 2025
Plandai Biotech's market capitalization history from 2015 to 2025. Data shows change from $2.18 Billion to $4.49 Million (-50.96% CAGR).
Plandai Biotech Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Plandai Biotech's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
30.08x
Plandai Biotech's market cap is 30.08 times its annual revenue
1.22x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.18 Billion | $92.90K | -$9.58 Million | 23484.16x | N/A |
| 2016 | $1.16 Billion | $92.90K | -$9.58 Million | 12515.22x | N/A |
| 2017 | $951.66 Million | $411.99K | -$4.01 Million | 2309.91x | N/A |
| 2023 | $8.98 Million | $298.49K | -$19.80 Million | 30.08x | N/A |
Competitor Companies of PLPL by Market Capitalization
Companies near Plandai Biotech in the global market cap rankings as of March 19, 2026.
Key companies related to Plandai Biotech by market ranking:
- Cintas Corporation (NASDAQ:CTAS): Ranked #341 globally with a market cap of $63.40 Billion USD.
- Relx PLC (PINK:RLXXF): Ranked #388 globally with a market cap of $56.43 Billion USD.
- Copart Inc (NASDAQ:CPRT): Ranked #699 globally with a market cap of $29.14 Billion USD.
- Thomson Reuters Corp (NYSE:TRI): Ranked #874 globally with a market cap of $22.59 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #341 | Cintas Corporation | NASDAQ:CTAS | $63.40 Billion | $185.44 |
| #388 | Relx PLC | PINK:RLXXF | $56.43 Billion | $48.91 |
| #699 | Copart Inc | NASDAQ:CPRT | $29.14 Billion | $33.00 |
| #874 | Thomson Reuters Corp | NYSE:TRI | $22.59 Billion | $165.98 |
Plandai Biotech Historical Marketcap From 2015 to 2025
Between 2015 and today, Plandai Biotech's market cap moved from $2.18 Billion to $ 4.49 Million, with a yearly change of -50.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $4.49 Million | -50.00% |
| 2024 | $8.98 Million | 0.00% |
| 2023 | $8.98 Million | -33.33% |
| 2022 | $13.47 Million | -50.00% |
| 2021 | $26.93 Million | +100.00% |
| 2020 | $13.47 Million | -50.00% |
| 2019 | $26.93 Million | -64.71% |
| 2018 | $76.31 Million | -91.98% |
| 2017 | $951.66 Million | -18.15% |
| 2016 | $1.16 Billion | -46.71% |
| 2015 | $2.18 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Plandai Biotech was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.49 Million USD |
| MoneyControl | $4.49 Million USD |
| MarketWatch | $4.49 Million USD |
| marketcap.company | $4.49 Million USD |
| Reuters | $4.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.